Physician profile
Sunil John
NPI 1427154665
$3,168.82
in general payments reported to CMS, 2019-2025
21 companies · $471 in 2025
The $471 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,034 · 2021: $98.43 · 2022: $172 · 2023: $611 · 2024: $782 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,783 · Education: $81.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,782.53 |
| Education | $81.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $723.58 | 2019-2025 | |
| Pfizer INC. | $561.41 | 2019-2025 | |
| Amgen INC. | $323.46 | 2023-2025 | Otezla, Krystexxa, Tavneos |
| Janssen Biotech, INC. | $233.54 | 2022-2025 | Tremfya, Simponi Aria |
| Ucb, INC. | $233.35 | 2019-2025 | Bimzelx |
| Celgene Corporation | $152.38 | 2019 | |
| Lilly USA, LLC | $141.50 | 2019-2024 | Taltz |
| Novartis Pharmaceuticals Corporation | $124.71 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.37 | 2019 | |
| Genzyme Corporation | $109.48 | 2019 | |
| Sanofi-Aventis U.S. LLC | $99.00 | 2019 | |
| Janssen Scientific Affairs, LLC | $92.24 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $81.75 | 2023-2024 | Orencia |
| Horizon Therapeutics Plc | $42.65 | 2023 | Krystexxa |
| Celltrion USA INC. | $26.75 | 2023 | Yuflyma |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius Kabi USA, LLC | $25.88 | 2024 | Idacio |
| Scilex Pharmaceuticals INC. | $18.32 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $15.39 | 2022 | |
| Exact Sciences Corporation | $15.25 | 2023 | Cologuard Collection Kit |
| Radius Health, INC. | $13.24 | 2022 | |
| Medexus Pharma, INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.